Androgen receptor axis-targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer

The present study aimed to use real-world Japanese data to compare the treatment outcome of conventional hormonal therapy to that of using androgen receptor axis-targeted (ARAT) agents for patients with metastatic castration-resistant prostate cancer. The overall survival between the conventional ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Akinori, Narita, Mitsuhiro, Nagasawa, Masayuki, Kusaba, Takuto, Kubota, Shigehisa, Yoshida, Tetsuya, Johnin, Kazuyoshi, Kawauchi, Akihiro, Kageyama, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404690/
https://www.ncbi.nlm.nih.gov/pubmed/36039059
http://dx.doi.org/10.3892/ol.2022.13453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404690/
https://www.ncbi.nlm.nih.gov/pubmed/36039059
http://dx.doi.org/10.3892/ol.2022.13453

Ejemplares similares